Dashboard
Manage Tickers

FDMT 4D Molecular Therapeutics, ...

Nasdaq 4dmoleculartherapeutics.com


$ 10.40 $ -0.24 (-2.23 %)    

Wednesday, 05-Nov-2025 17:56:25 EST
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 622.38 $ 4.94 (0.8 %)
DIA $ 473.04 $ 2.23 (0.47 %)
SPY $ 677.28 $ 2.47 (0.37 %)
TLT $ 89.01 $ -0.57 (-0.64 %)
GLD $ 365.20 $ 0.10 (0.03 %)
$ 10.51
$ 10.65
$ 10.00 x 47
$ 10.60 x 98
$ 10.33 - $ 10.93
$ 2.24 - $ 12.34
631,608
na
589.48M
$ 1.62
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-11-2025 06-30-2025 10-Q
2 05-08-2025 03-31-2025 10-Q
3 02-28-2025 01-01-1970 10-K
4 11-13-2024 09-30-2024 10-Q
5 08-08-2024 06-30-2024 10-Q
6 05-09-2024 03-31-2024 10-Q
7 02-29-2024 12-31-2023 10-K
8 11-09-2023 09-30-2023 10-Q
9 08-09-2023 06-30-2023 10-Q
10 05-11-2023 03-31-2023 10-Q
11 03-15-2023 12-31-2022 10-K
12 11-08-2022 09-30-2022 10-Q
13 08-11-2022 06-30-2022 10-Q
14 05-12-2022 03-31-2022 10-Q
15 03-28-2022 12-31-2021 10-K
16 11-10-2021 09-30-2021 10-Q
17 08-12-2021 06-30-2021 10-Q
18 05-13-2021 03-31-2021 10-Q
19 03-25-2021 12-31-2020 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

reported-earlier-4dmt-and-otsuka-pharmaceutical-sign-85m-upfront-license-deal-with-up-to-336m-in-milestones-to-develop-and-commercialize-4d-150-across-asia-pacific
Reported Earlier, 4DMT And Otsuka Pharmace...
10/31/2025 07:49:40

4DMT to receive $85 million upfront cash payment and expect to receive at least $50 million of cost sharing from Otsuka over th...

beyond-the-numbers-4-analysts-discuss-4d-molecular-therapeutics-stock
Beyond The Numbers: 4 Analysts Discuss 4D ...
10/21/2025 21:00:57

rbc-capital-reiterates-outperform-on-4d-molecular-therapeutics-maintains-26-price-target
RBC Capital Reiterates Outperform on 4D Mo...
10/21/2025 14:28:01

RBC Capital analyst Lisa Walter reiterates 4D Molecular Therapeutics (NASDAQ:FDMT) with a Outperform and maintains $26 price...

Core News & Articles
10 Health Care Stocks Whale Activity In To...
10/08/2025 17:35:32

on-sept-30-4d-molecular-therapeutics-appointed-ashoo-gupta-as-principal-financial-officer-effective-immediately
On Sept 30, 4d Molecular Therapeutics Appo...
10/02/2025 20:12:01

-SEC Filing

Core News & Articles
12 Health Care Stocks Moving In Thursday's...
09/04/2025 12:08:12

jim-cramer-applovin-calls-for-prudence-this-health-care-stock-is-pure-spec
Jim Cramer: AppLovin Calls For Prudence, T...
09/03/2025 11:46:59

Jim Cramer doesn't recommend buying more AppLovin stock. "Let's take a little off the table just to be prudent,"...

4d-molecular-therapeutics-says-4front-1-phase-3-trial-enrollment-continues-to-exceed-expectations-with-enrollment-completion-now-expected-in-q1-2026
4D Molecular Therapeutics Says 4FRONT-1 Ph...
09/02/2025 12:14:19

what-4-analyst-ratings-have-to-say-about-4d-molecular-therapeutics
What 4 Analyst Ratings Have To Say About 4...
08/12/2025 19:01:25

roth-capital-maintains-buy-on-4d-molecular-therapeutics-lowers-price-target-to-38
Roth Capital Maintains Buy on 4D Molecular...
08/12/2025 17:49:17

Roth Capital analyst Salveen Richter maintains 4D Molecular Therapeutics (NASDAQ:FDMT) with a Buy and lowers the price targe...

chardan-capital-maintains-buy-on-4d-molecular-therapeutics-maintains-25-price-target
Chardan Capital Maintains Buy on 4D Molecu...
08/12/2025 10:49:51

Chardan Capital analyst Geulah Livshits maintains 4D Molecular Therapeutics (NASDAQ:FDMT) with a Buy and maintains $25 price...

4d-molecular-therapeutics-q2-eps-098-misses-085-estimate-sales-15000k-miss-374143k-estimate
4D Molecular Therapeutics Q2 EPS $(0.98) M...
08/11/2025 12:17:31

4D Molecular Therapeutics (NASDAQ:FDMT) reported quarterly losses of $(0.98) per share which missed the analyst consensus estim...

Core News & Articles
12 Health Care Stocks Moving In Monday's I...
08/04/2025 17:06:36

assessing-4d-molecular-therapeutics-insights-from-5-financial-analysts
Assessing 4D Molecular Therapeutics: Insig...
08/01/2025 22:04:04

4d-molecular-therapeutics-rallies-on-heels-of-diabetes-related-vision-study
4D Molecular Therapeutics Rallies On Heels...
08/01/2025 14:29:21

4D Molecular's 4D-150 showed sustained vision and anatomical improvements with fewer injections in DME, supported by regula...

Core News & Articles
12 Health Care Stocks Moving In Friday's P...
08/01/2025 12:07:59

Core News & Articles
Market-Moving News for August 1st
08/01/2025 11:15:14

FIG: 28% | Figma shares are trading higher on momentum following Thursday's IPO. COIN: -11% | Coinbase shares are trading l...

why-apple-shares-are-trading-higher-here-are-20-stocks-moving-premarket
Why Apple Shares Are Trading Higher; Here ...
08/01/2025 10:56:59

Core News & Articles
12 Health Care Stocks Moving In Thursday's...
07/31/2025 21:07:05

4dmt-presents-results-of-4d-150-spectra-clinical-trial-in-dme-and-regulatory-update
4DMT Presents Results Of 4D-150 SPECTRA Cl...
07/31/2025 20:25:24

4D-150 continues to be well tolerated with no intraocular inflammation observed at any timepoint or dose level4D-150 demonstrat...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION